Topic List : Precision Health
Helping women identify their risk for cancer
Researchers assigned levels of risk to 25 mutations associated with breast and ovarian cancer in a large, Stanford-led study. The results may be helpful in guiding treatment and screening recommendations.
New technology provides rare diagnosis
Stanford scientists have used a next-generation technology called long-read sequencing to diagnose a patient’s rare genetic condition that current technology failed to diagnose.
Data sifting finds hidden gene partnerships
Targeting backup biological pathways often used by cancers can lead to more efficient drug development and less-toxic therapies. Stanford researchers have developed a new way to identify these pathways.
Integrating diverse data key to precision health
At the Big Data in Biomedicine Conference, Dean Lloyd Minor said a key goal is tackling population health and disease prevention, not just waiting for illness to strike.
How accurate are fitness devices?
A Stanford inquiry into the accuracy of seven wristband activity monitors showed that six out of seven devices measured heart rate within 5 percent. None, however, measured energy expenditure well.
Big data conference set for May 24-25
The two-day event at Stanford will focus on ways of using big data to advance precision health.
Protein helps speed wound healing
Pretreatment with a stem-cell-activating protein significantly enhances healing in mice, Stanford researchers say. The approach could eventually help people going into surgery or combat heal better from injuries they sustain.
Wearable monitor can diagnose disease
A wearable sensor developed by Stanford researchers can diagnose diseases by measuring molecular constituents of sweat, such as chloride ions and glucose.
Diagnosing cancer without biopsy
A Stanford-led team of researchers has developed tiny bubbles that bind to malignant tumors, making them visible to ultrasound imaging.
Heart-damaging chemo drugs ranked
Stanford researchers have developed a test that may help screen for cardiotoxicity in new chemotherapy drugs.